Neoplasma 2013-01-01

The effect of prolactin and estrogen cross-talk on prolidase- dependent signaling in MCF-7 cells.

A Surazynski, W Miltyk, S Wolczynski, J Palka

Index: Neoplasma 60(4) , 355-63, (2013)

Full Text: HTML

Abstract

Estrogen and prolactin play important role in mammary carcinogenesis. The present study was undertaken to evaluate the effect of prolactin and estrogen cross-talk on HIF-1 α level and expression of some HIF-1 α- dependent signaling proteins. Since up-regulation of prolidase activity inhibits HIF-1 α degradation, the enzyme was considered as an interface of estrogen/prolactin signaling. The experiments were performed on MCF-7 cells cultured with prolactin in the presence or absence of estradiol. It was found that in the presence of estradiol, prolactin inhibits prolidase activity and its down-stream signaling proteins: HIF-1α, mTOR, AKT and MAPK p-38, while in the absence of estradiol, an opposite effect was observed. These results suggest that prolactin/estrogen cross-talk exert beneficial effect on prolidase-dependent down regulation of HIF-1α. It suggests that dual action of prolactin and estrogen may be considered as a strategy in therapy of breast cancer.


Related Compounds

  • Prolactin, Human...
  • Dipeptidase, Prol...
  • Hexokinase

Related Articles:

Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation.

2014-05-01

[Genes Dev. 28(9) , 983-94, (2014)]

Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.

2014-10-01

[J. Clin. Oncol. 32(28) , 3111-7, (2014)]

Longer anogenital distance is associated with higher testosterone levels in women: a cross-sectional study.

2014-10-01

[BJOG 121(11) , 1359-64, (2014)]

[Specifics of hormonal and energy balance in patients with hyperplasia and endometrial neoplasia with metabolic syndrome in the background].

2013-01-01

[Vopr. Onkol. 59(1) , 65-71, (2013)]

Anti-metastatic outcome of isoform-specific prolactin receptor targeting in breast cancer

2015-09-28

[Cancer Lett. 366 , 84-92, (2015)]

More Articles...